Article contents
American Psychopharmacology: Second Class Status?
Published online by Cambridge University Press: 29 January 2018
Extract
In the July 1964 issue of The Atlantic, William Sargant (6), made some controversial comments on American psychiatry. “Freudian converts”, he said, fear “allowing any other methods of psychiatric treatment to gain any real recognition and acceptance in … teaching centers” where physical and biochemical treatments are “dismissed” as “symptomatic” and “second-rate”. He argued, furthermore, that psychoanalysts' views are unrealistic because these practitioners are experienced merely with the “very mildest forms of mental illness”. “Only psychoanalysis holds out any real hope in treatment” is the credo which Dr. Sargant attributes to U.S. psychoanalysts. If these opinions were solely those of one author, they might be overlooked, but they are held by many European and American psychiatrists (1).
- Type
- Research Article
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1967
References
- 1
- Cited by
eLetters
No eLetters have been published for this article.